On Sep. 12, SEC charged hedge fund for short-and-distort scheme. Lemelson Capital profited from driving down price of Ligand Pharmaceuticals. Alleged Violations Defendant took a short position in May 2014, on behalf of The Amvona Fund. Gregory Lemelson then issued false information about Ligand so the price fell. Ligand’s stock lost more than one-third of…
Read more
